Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: Detection rate of pelvic lymph node metastases

BJU International

Volumn 109, Issue 7, 2012, Pages 1031-1036

  Papalia, Rocco ^a,b   Simone, Giuseppe ^b   Grasso, Rosario ^a   Augelli, Raffaele ^a   Faiella, Eliodoro ^a   Guaglianone, Salvatore ^b   Cazzato, Roberto ^a   Vescovo, Riccardo Del ^a   Ferriero, Mariaconsiglia ^a   Zobel, Bruno ^a   Gallucci, Michele ^b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

bladder cancer; diffusion weighted MRI; extended pelvic lymphadenectomy; lymph node metastasis

Indexed keywords

PROTEIN P21; PROTEIN P27; PROTEIN P53;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; AREA UNDER THE CURVE; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; PELVIS LYMPH NODE; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; CYSTECTOMY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PELVIS; URINARY BLADDER NEOPLASMS;

EID: 84858439898     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10446.x     Document Type: Article

References (37)

1. Bladder cancer. National Cancer Institute website. Available at:. Accessed February 2010
2. Kaufman DS, Shipley WU, Feldman AS,. Bladder cancer. Lancet 2009; 374: 239-49
3. Stein JP, Lieskovsky G, Cote R, et al,. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001; 19: 666-75 (Pubitemid 32120143)
4. Leissner J, Ghoneim MA, Abol-Enein H, et al,. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004; 171: 139-44 (Pubitemid 37549109)
5. Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP,. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004; 171: 1830-4 (Pubitemid 38501015)
6. Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA,. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 2004; 172: 85-9 (Pubitemid 41615044)
7. Bochner BH, Cho C, Herr HW, Donat M, Kattan MW, Dalbagni G,. Prospective packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol 2004; 172: 1286-90 (Pubitemid 39249699)
8. Paik ML, Scolieri MJ, Brown SL, Spirnak JP, Resnick MI,. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 2000; 163: 1693-6 (Pubitemid 30366715)
9. Schoder H, Larson SM,. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004; 34: 274-92 (Pubitemid 39365998)
10. Powles T, Murray I, Brock C, Oliver T, Avril N,. Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol 2007; 51: 1511-21 (Pubitemid 46634756)
11. Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E,. Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECTCT. Eur J Nucl Med Mol Imaging 2006; 33: 329-37
12. Liedberg F, Månsson W,. Lymph node metastasis in bladder cancer. Eur Urol 2006; 49: 13-21 (Pubitemid 41789948)
13. Deserno WM, Harisinghani MG, Taupitz M, et al,. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 2004; 233: 449-56 (Pubitemid 39423804)
14. Koh DM, Collins DJ,. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol 2007; 188: 1622-35 (Pubitemid 46866868)
15. Stein JP,. The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer. Curr Oncol Rep 2007; 9: 213-21 (Pubitemid 46744751)
16. Benedict WF, Lerner SP, Zhou J, et al,. Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer. Oncogene 1999; 18: 1197-203 (Pubitemid 29085992)
17. Shariat SF, Tokunaga H, Zhou J, et al,. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol 2004; 22: 1014-24 (Pubitemid 41095033)
18. Shariat SF, Zlotta AR, Ashfaq R, et al,. Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness. Mod Pathol 2007; 20: 445-59 (Pubitemid 46482368)
19. Shariat SF, Ashfaq R, Sagalowsky AI, et al,. Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis. Hum Pathol 2006; 37: 1568-76 (Pubitemid 44792223)
20. El-Assmy A, Abou-El-Ghar ME, Mosbah A, et al,. Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging. Eur Radiol 2009; 19: 1575-81
21. Takeuchi M, Sasaki S, Ito M, et al,. Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009; 251: 112-21
22. Steven K, Poulsen AL,. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common ileac vessels treated with surgery only. J Urol 2007; 178: 1218-23
23. Wright JL, Lin DW, Porter MP,. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 2008; 112: 2332-3
24. Dhar NB, Klein EA, Reuther AM, et al,. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008; 179: 873-8
25. Poulsen AL, Horn T, Steven K,. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998; 160: 2015-9
26. Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ,. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared rapid gradient-echo sequence. Am J Roentgenol 1996; 167: 1503-7 (Pubitemid 26418741)
27. Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C,. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. Am J Roentgenol 2000; 175: 759-66
28. Barentsz JO, Engelbrecht MR, Witjes JA, de la Rosette JJ, van der Graaf M,. MR imaging of the male pelvis. Eur Radiol 1999; 9: 1722-36
29. Dorfman RE, Alpern MB, Gross BH, Sandler MA,. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 1991; 180: 319-22
30. Swinnen G, Maes A, Pottel H, et al,. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol 2010; 57: 641-7
31. 18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 2009; 27: 4314-20
32. Saremi F, Knoll AN, Bendavid OJ, Schultze-Haakh H, Narula N, Sarlati F,. Characterization of genitourinary lesions with diffusion-weighted imaging. Radiographics 2009; 29: 1295-317
33. 18F]fluoro-2-deoxyglucose positron emission tomography scan staging prior to planned radical hysterectomy and pelvic lymphadenectomy. Int J Gynecol Cancer 2005; 15: 1060-4 (Pubitemid 43110153)
34. Vandecaveye V, De Keyzer F, Vander Poorten V, et al,. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009; 251: 134-46
35. Kim JK, Kim KA, Park BW, Kim N, Cho KS,. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imag 2008; 28: 714-9
36. Lin G, Ho KC, Wang JJ, et al,. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imag 2008; 28: 128-35 (Pubitemid 351956475)
37. Goh AC, Lerner SP,. Application of new technology in bladder cancer diagnosis and treatment. World J Urol 2009; 27: 301-7